Atlas Trials

Thymus Regeneration, Immunorestoration, and Insulin Mitigation Extension Trial

Clinical trial NCT04375657 · RECRUITING

Trial details

NCT number
NCT04375657
Sponsor
Intervene Immune, Inc.
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Epigenetic AgingImmunosenescence
Start date
2020-11-23
Primary completion
2025-12-01
Enrollment
85

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.